Search Results

Business

Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights

Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.

May 13, 2024

·

6 min read

Biotech Beach

THINK Surgical to Collaborate with b-ONE Ortho Corporation for Robotic TKA

THINK Surgical, Inc. announced that it will enter into a new Collaboration Agreement with b-ONE Ortho Corporation.

February 14, 2024

·

3 min read

Ortho Development Receives FDA Clearance on Trivicta Hip System

Ortho Development Corporation, a designer and manufacturer of orthopedic implants and instruments for hip and knee joint replacement surgery, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Trivicta™ Hip System.

March 14, 2024

·

1 min read

Business

Ortho Regenerative Technologies Announces Corporate Name Change to ChitogenX

Ortho Regenerative Technologies Inc. announced that it has changed its corporate name to ChitogenX Inc. to better reflect the Company’s expanded clinical and commercial opportunities, mission, values, and core competencies.

September 7, 2022

·

3 min read

Press Releases

Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors

August 28, 2024

·

4 min read

Business

Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported fourth quarter and full year 2023 financial results.

April 2, 2024

·

9 min read

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR

Ortho Regenerative Technologies Inc. announced today that it has received, through its partnership with Polytechnique Montreal, a $500,000 non-dilutive grant from Axelys, to advance the development of its second technology platform indication, ORTHO-M, for meniscus repair.

May 26, 2022

·

3 min read

Genetown

Morphoceuticals Names Jim Jenson, PhD as CEO to Advance AI-Guided Regenerative Medicine Technology

Morphoceuticals Inc. announced the appointment of veteran biotech executive Jim Jenson, PhD, as CEO. Jenson joins a growing team and will lead the company as it advances its novel regenerative medicine technology platform.

April 18, 2024

·

3 min read

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORM

Ortho Regenerative Technologies Inc. announced today that the United States Patent and Trademark Office (the “USPTO”) has issued a patent related to the Company’s ORTHO-R soft tissue repair platform.

May 4, 2022

·

3 min read

Press Releases

QC Kinetix National Medical Director Dr. Mitchell Sheinkop is the Keynote Speaker at the International Conference on Stem Cells and Regenerative Medicine

November 12, 2024

·

3 min read